What is Plume?
Plume operates at the intersection of healthcare innovation and digital accessibility, providing a dedicated telehealth platform for gender-affirming hormone therapy. By removing traditional barriers to care, the company offers a streamlined, patient-centric experience that connects individuals with specialized medical providers. Its market position is defined by its commitment to the trans-community, utilizing a subscription-based model that ensures consistent, high-quality clinical support. As the demand for specialized digital health services continues to rise, Plume remains at the forefront of the industry, effectively bridging the gap between patients and essential medical services through a secure, technology-enabled infrastructure.
How much funding has Plume raised?
Plume has raised a total of $38M across 2 funding rounds:
Series A
$14M
Series B
$24M
Series A (2021): $14M with participation from Town Hall Ventures, General Catalyst, Slow Ventures, and Craft Ventures
Series B (2022): $24M led by Townhall Ventures, General Catalyst, and Transformation Capital
Key Investors in Plume
General Catalyst
General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, including healthcare and technology, by providing strategic capital and operational expertise.
Transformation Capital
Transformation Capital is a growth equity fund headquartered in Boston that specializes in backing innovative healthcare IT and services companies.
Town Hall Ventures
Town Hall Ventures partners with visionary entrepreneurs to address long-standing healthcare challenges for underserved communities, focusing on building transformative and scalable care delivery businesses.
What's next for Plume?
With the successful closure of its latest financing round, Plume is poised for a phase of aggressive market expansion and service diversification. The company is expected to utilize these resources to broaden its geographic footprint and potentially integrate additional health services into its existing platform. Strategic priorities likely include enhancing the patient experience through technological upgrades, expanding the provider network to meet growing demand, and strengthening its position as a category-defining entity in the digital health space. As Plume continues to scale, the focus will remain on maintaining clinical excellence while navigating the complexities of the U.S. healthcare regulatory environment, ensuring that its growth remains sustainable and impactful for its user base.
See full Plume company page
